Literature DB >> 11151443

Pheochromocytoma cell lines from heterozygous neurofibromatosis knockout mice.

J F Powers1, M J Evinger, P Tsokas, S Bedri, J Alroy, M Shahsavari, A S Tischler.   

Abstract

Transplantable tumors and cell lines have been developed from pheochromocytomas arising in mice with a heterozygous knockout mutation of the neurofibromatosis gene, Nf1. Nf1 encodes a ras-GTPase-activating protein, neurofibromin, and mouse pheochromocytoma (MPC) cells in primary cultures typically show extensive spontaneous neuronal differentiation that may result from the loss of the remaining wild-type allele and defective regulation of ras signaling. However, all MPC cell lines express neurofibromin, suggesting that preservation of the wild-type allele may be required to permit the propagation of MPC cells in vitro. MPC lines differ from PC12 cells in that they express both endogenous phenylethanolamine N-methyltransferase (PNMT) and full-length PNMT reporter constructs. PNMT expression is increased by dexamethasone and by cell-cell contact in suspension cultures. Mouse pheochromocytomas are a new tool for studying genes and signaling pathways that regulate cell growth and differentiation in adrenal medullary neoplasms and are a unique model for studying the regulation of PNMT expression.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11151443     DOI: 10.1007/s004410000290

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  57 in total

1.  Increased uptake of [¹²³I]meta-iodobenzylguanidine, [¹⁸F]fluorodopamine, and [³H]norepinephrine in mouse pheochromocytoma cells and tumors after treatment with the histone deacetylase inhibitors.

Authors:  Lucia Martiniova; Shiromi M Perera; Frederieke M Brouwers; Salvatore Alesci; Mones Abu-Asab; Amanda F Marvelle; Dale O Kiesewetter; David Thomasson; John C Morris; Richard Kvetnansky; Arthur S Tischler; James C Reynolds; Antonio Tito Fojo; Karel Pacak
Journal:  Endocr Relat Cancer       Date:  2011-01-13       Impact factor: 5.678

2.  Usefulness of [18F]-DA and [18F]-DOPA for PET imaging in a mouse model of pheochromocytoma.

Authors:  Lucia Martiniova; Susannah Cleary; Edwin W Lai; Dale O Kiesewetter; Jurgen Seidel; Linda F Dawson; Jacqueline K Phillips; David Thomasson; Xiaoyuan Chen; Graeme Eisenhofer; James F Powers; Richard Kvetnansky; Karel Pacak
Journal:  Nucl Med Biol       Date:  2011-09-29       Impact factor: 2.408

3.  Nicotine stimulates expression of the PNMT gene through a novel promoter sequence.

Authors:  Marian J Evinger; Elizabeth Mathew; Stefan Cikos; James F Powers; Ying-Shuan E Lee; Sabina Sheikh; Robert A Ross; Arthur S Tischler
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

4.  Adenoviral gene transfer in bovine adrenomedullary and murine pheochromocytoma cells: potential clinical and therapeutic relevance.

Authors:  Salvatore Alesci; Shiromi M Perera; Edwin W Lai; Christina Kukura; Mones Abu-Asab; Maria Tsokos; John C Morris; Karel Pacak
Journal:  Endocrinology       Date:  2007-05-24       Impact factor: 4.736

5.  Mitochondrial localization of human recombinant adenovirus: from evolution to gene therapy.

Authors:  Salvatore Alesci; Mones Abu-Asab; Shiromi M Perera; Maria Tsokos; John C Morris; Karel Pacak
Journal:  Neuroimmunomodulation       Date:  2008-01-25       Impact factor: 2.492

6.  Cell based therapy for the management of chronic pain.

Authors:  Younghoon Jeon
Journal:  Korean J Anesthesiol       Date:  2011-01-28

7.  A unique model for SDH-deficient GIST: an endocrine-related cancer.

Authors:  James F Powers; Brent Cochran; James D Baleja; Hadley D Sikes; Xue Zhang; Inna Lomakin; Troy Langford; Kassi Taylor Stein; Arthur S Tischler
Journal:  Endocr Relat Cancer       Date:  2018-07-02       Impact factor: 5.678

Review 8.  Rodent models of pheochromocytoma, parallels in rodent and human tumorigenesis.

Authors:  Charlotte Lussey-Lepoutre; Alexandre Buffet; Aurélie Morin; Judith Goncalves; Judith Favier
Journal:  Cell Tissue Res       Date:  2018-02-09       Impact factor: 5.249

9.  Overexpression of interleukin-13 receptor-alpha2 in neuroendocrine malignant pheochromocytoma: a novel target for receptor directed anti-cancer therapy.

Authors:  Edwin W Lai; Bharat H Joshi; Lucia Martiniova; Ritika Dogra; Toshio Fujisawa; Pamela Leland; Ronald R de Krijger; Irina A Lubensky; Abdel G Elkahloun; John C Morris; Raj K Puri; Karel Pacak
Journal:  J Clin Endocrinol Metab       Date:  2009-06-02       Impact factor: 5.958

10.  Aldo keto reductase 1B7 and prostaglandin F2alpha are regulators of adrenal endocrine functions.

Authors:  Sarah Lambert-Langlais; Jean-Christophe Pointud; Anne-Marie Lefrançois-Martinez; Fanny Volat; Michèle Manin; François Coudoré; Pierre Val; Isabelle Sahut-Barnola; Bruno Ragazzon; Estelle Louiset; Catherine Delarue; Hervé Lefebvre; Yoshihiro Urade; Antoine Martinez
Journal:  PLoS One       Date:  2009-10-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.